Abstract
Meningiomas usually are slowly growing brain tumors histologically classified as grade 1 according to the criteria of the World Health Organization (WHO) [26]. Nevertheless, some meningiomas tend to proliferate more rapidly, resulting in an increased incidence of local recurrences up to malignant meningiomatosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bachrach U (1976) Polyamines as chemical markers of malignancy. Ital J Biochem 25:77–93
Böker DK, Stark HJ (1988) The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimens. Neurosurg Rev 11:267–272
Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10:611–617
Deckert M, Reifenberger G, Wechsler W (1989) Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 115:179–188
Ermestus RI, Röhn G, Paschen W (1991) Polyamine metabolism in experimental brain tumors of rat. J Cereb Blood Flow Metab 11Suppl 2:548
Emestus RI, Röhn G, Schröder R, Klug N, Hossmann KA, Paschen W (1992) Activity of ornithine decarboxylase (ODC) and polyamine levels as biochemical markers of malignacy in brain tumors. Acta Histochem Suppl (Jena) 42:159–164
Gerdes J, Schwab U,. Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20
Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 31:1710–1715
Giangasparo F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H (1987) Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 74:179–182
Horn Y, Beal SL, Walach N, Lubich WP, Spigel L, Marton LJ (1982) Further evidence for the use of polyamines as biochemical markers for malignant tumors. Cancer Res 42:3248–3251
Iwaki T, Takeshita I, Fukui M, Kitamaura K (1987) Cell kinetics of the malignant evolution of meningoendothelial meningioma. Acta Neuropathol (Berl) 74:243–247
Jänne J, Pösö H, Raina A (1978) Polyamines in rapid growth and cancer. Biochim Biophys Acta 473:241–293
Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET (1991) Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl) 81:675–679
Morimura T, Kitz K, Stein H, Budka H (1991) Determination of proliferative activities in human brain tumor specimens: a comparison of three methods. J Neurooncol 10:1–11
Ostertag CB, Volk B, Shibata T, Burger P, Kleihues P (1987) The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsis of brain tumours. Acta Neurochir (Wien) 89:117–121
Paschen W, Röhn G, Meese CO, Djuricic B, Schmidt-Kastner R (1988) Polyamine metabolism in reversible cerebral ischemia. Effect of α-difluoromethylomithine. Brain Res 453:9–16
Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D (1988) Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. Anticancer Res 8:537–544
Plate KH, Rüschoff J, Behnke J, Mennel HD (1990) Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki-67-immunoreactivity. Acta Neurochir (Wien) 104:103–109
Roggendorf W, Schuster T, Pfeiffer J (1987) Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 73:361–364
Russell DH, Haddox MK (1978) Cyclic AMP-mediated induction of ornithine decarboxylase in normal and neoplastic growth. Adv Enzyme Regul 17:61–79
Scalabrino G, Ferioli ME (1985) Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: a useful new index of degree of malignancy. Cancer Detect Prev 8:11–16
Schröder R, Bien K, Kott R, Meyer I, Vössing R (1991) The relationship between Ki-67 labelling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time. Acta Neuropathol (Berl) 82:389–394
Shibata T, Burger PC, Kleihues P (1988) Ki-67 immunoperoxidase stain as a marker for the histological grading of nervous system tumours. Acta Neurochir Suppl (Wien) 43:103–106
Shibata T, Ostertag CB, Volk B (1989) Ki-67 PAP stain for histologic grading of brain tumors by squash preparations. No To Shinkei 41:55–60
Shiraishi T (1990) Cell kinetic analysis of brain tumors using the monoclonal antibody Ki-67: in vitro and in situ study. Acta Med Okayama 43:187–201
Zülch KJ (1986) Brain tumors. Their biology and pathology. 3rd edn. Springer, Berlin Heidelberg New York
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ernestus, R.I., Schröder, R., Röhn, G., Klug, N., Hossmann, K.A., Paschen, W. (1993). Activity of Ornithine Decarboxylase and Ki-67 Index in Meningiomas. In: Lorenz, R., Klinger, M., Brock, M. (eds) Intracerebral Hemorrhage Hydrocephalus malresorptivus Peripheral Nerves. Advances in Neurosurgery, vol 21. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77997-8_57
Download citation
DOI: https://doi.org/10.1007/978-3-642-77997-8_57
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56304-4
Online ISBN: 978-3-642-77997-8
eBook Packages: Springer Book Archive